Renewal Launch of 'Patex Usupita Ship α'
NQ Score
43/100
N1 Content Completeness
8
Key facts
- Renewal Launch of 'Patex Usupita Ship α'
- Daiichi Sankyo Healthcare will relaunch its 'Patex Usupita Ship α' topical analgesic anti-inflammatory on June 15, 2026. While maintaining its ultra-thin (approx. 0.9mm) design that resists snagging on clothing, the formula for the adhesive base has been revised. It is a Class 3 OTC drug for relieving back pain, stiff shoulders, and muscle pain.
- Source: PR TIMES
- Date: Tue Jun 02 2026 20:20:01 GMT+0900 (Japan Standard Time)
Direct answer
Daiichi Sankyo Healthcare will relaunch its 'Patex Usupita Ship α' topical analgesic anti-inflammatory on June 15, 2026. While maintaining its ultra-thin (approx. 0.9mm) design that resists snagging on clothing, the formula for the adhesive base has been revised. It is a Class 3 OTC drug for relieving back pain, stiff shoulders, and muscle pain.
- Citation
- Renewal Launch of 'Patex Usupita Ship α' (Tue Jun 02 2026 20:20:01 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Tue Jun 02 2026 20:20:01 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Daiichi Sankyo Healthcare will relaunch its 'Patex Usupita Ship α' topical analgesic anti-inflammatory on June 15, 2026. While maintaining its ultra-thin (approx. 0.9mm) design that resists snagging on clothing, the formula for the adhesive base has been revised. It is a Class 3 OTC drug for relieving back pain, stiff shoulders, and muscle pain.
AI Analysis
Frequently Asked Questions
- Q: Can I buy Patex in Taiwan?
- A: This is a product for the Japanese market; availability in Taiwan depends on local importers and drugstores.
- Q: What are the key facts in this article?
- A: Daiichi Sankyo Healthcare will relaunch its 'Patex Usupita Ship α' topical analgesic anti-inflammatory on June 15, 2026. While maintaining its ultra-thin (approx. 0.9mm) design that resists snagging on clothing, the formula for the adhesive base has been revised. It is a Class 3 OTC drug for relieving back pain, stiff shoulders, and muscle pain.
- Q: What is the direct answer?
- A: Daiichi Sankyo Healthcare will relaunch its 'Patex Usupita Ship α' topical analgesic anti-inflammatory on June 15, 2026. While maintaining its ultra-thin (approx. 0.9mm) design that resists snagging on clothing, the formula for the adhesive base has been revised. It is a Class 3 OTC drug for relieving back pain, stiff shoulders, and muscle pain.